About
Brian Stuglik was appointed to Chief Executive Officer (CEO) of Verastem Oncology in July, 2019. Mr. Stuglik is a global leader in the oncol...
Companies (2)
Verastem Oncology
View →Advisor
IPO130Needham, Massachusetts, United StatesBiopharma · Biotechnology
People at Eli Lilly
Adam Fleisher
Medical Fellow, Clinical Lead
Alessandro Maggio
Data Engineer
Alfonso G. Zulueta
President, International
Amy Meadows
Senior Advisor, Consumer Marketing
Anat Ashkenazi
Chief Financial Officer
Andrew Adams
Group Vice President - Molecule Discovery
Data from: crunchbase